2032, Global Artificial Intelligence (AI) in Drug Discovery Market Revenue Report

(MENAFN- Meridian market Consultants) The Global Artificial Intelligence (AI) In Drug Discovery Market is rapidly expanding due to its potential to revolutionize the pharmaceutical industry. AI enables the analysis of vast amounts of data at an unprecedented speed, helping to identify potential drug targets and streamline the drug development process. It offers improved accuracy, efficiency, and cost-effectiveness in predicting drug interaction, toxicity, and efficacy. The market is expected to witness significant growth in the coming years as more pharmaceutical companies adopt AI technologies for faster and more effective drug discovery.

Global artificial intelligence (AI) in drug discovery market will reach $2.57 billion by 2026, growing by 30.3% annually over 2020-2026 despite the COVID-19 impact.

"Get a taste of the expertise and insights our reports offer - download your free sample now!"

Highlighted with 86 tables and 86 figures, this 178-page report “Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region.

Based on offering, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

Software
Service

Based on technology, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

Deep Learning
Supervised Learning
Reinforcement Learning
Unsupervised Learning
Other Technologies

To view Top Players, Segmentation and other Statistics of Global Artificial Intelligence (AI) in Drug Discovery Industry, Get Free Customization Report:

Based on drug type, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

Large-molecule Drugs
Small-molecular Drugs

Based on therapeutic area, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

Oncology
Neurodegenerative Diseases
Cardiovascular Disease
Metabolic Diseases
Other Therapeutic Areas

Some of the key questions answered in this report: 

Which are the five top players of the Global Artificial Intelligence (AI) in Drug Discovery Market?
How will the Global Artificial Intelligence (AI) in Drug Discovery Market change in the upcoming years?
Which product and application will take a share of the Global Artificial Intelligence (AI) in Drug Discovery Market?
What are the drivers and restraints of the Global Artificial Intelligence (AI) in Drug Discovery Market?
Which regional market will show the highest growth?
What will be the CAGR and size of the Global Artificial Intelligence (AI) in Drug Discovery Market throughout the forecast period?
What is the current market size, what will the market size be in 2030 and what will the growth rate be?
What are the challenges to grow in the market?
What are the market opportunities and challenges faced by the key vendors?
Who are the major competitors and what is their strategy?
What are the barriers to entry for new players in the market?

Based on application, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

Information & Data Analysis
Drug Design
Drug Evaluation
Clinical Trials
Other Applications

Based on end user, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations

Geographically, the following regions together with the listed national/local markets are fully investigated:

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
North America (U.S., Canada, and Mexico)
South America (Brazil, Chile, Argentina, Rest of South America)
RoW (Saudi Arabia, UAE, Egypt)

For each of the aforementioned regions and countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of all regional markets by country and split of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.

"Get Personalized Advice from An Industry Expert. Contact Us Today!"

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global AI in drug discovery market are assayed quantitatively and qualitatively through Market Data Library’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Atomwise, Inc.

BenevolentAI

Berg LLC

Bioage

BIOAGE

Cloud Pharmaceuticals, Inc.

Cyclica

Deep Genomics

Envisagenics

Exscientia

Google

IBM Corporation

Insilico Medicine

Microsoft Corporation

Numedii, Inc.

Numerate

NVIDIA Corporation

Owkin, Inc.

Twoxar, Incorporated

Verge Genomics

Xtalpi, Inc.

Latest Report:

About Market Data Library:

Market Data Library is committed to providing clients with high-quality market research that is tailored to their specific needs. The Market Data Library provides corporate intelligence studies that ensure reliable and accurate research data across a diverse range of industries, including Health Care, Chemicals, Packaging, ICT, Automotive, Industrial Automation, Agriculture, and Finance. Our team is comprised of various departments, including sales, operations, finance, research, and analytics, as well as the scientist and data scientist teams. Our business offerings portray the most up-to-date, rational information a company needs to compete effectively. To guarantee that our clients have access to information and insights whenever they need them, we provide 24/7 research support.

MENAFN14072023004629010566ID1106604755